Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT.

Noviello M, Manfredi F, Ruggiero E, Perini T, Oliveira G, Cortesi F, De Simone P, Toffalori C, Gambacorta V, Greco R, Peccatori J, Casucci M, Casorati G, Dellabona P, Onozawa M, Teshima T, Griffioen M, Halkes CJM, Falkenburg JHF, Stölzel F, Altmann H, Bornhäuser M, Waterhouse M, Zeiser R, Finke J, Cieri N, Bondanza A, Vago L, Ciceri F, Bonini C.

Nat Commun. 2019 Mar 25;10(1):1065. doi: 10.1038/s41467-019-08871-1.

2.

The Pathophysiological Relevance of the iNKT Cell/Mononuclear Phagocyte Crosstalk in Tissues.

Cortesi F, Delfanti G, Casorati G, Dellabona P.

Front Immunol. 2018 Oct 12;9:2375. doi: 10.3389/fimmu.2018.02375. eCollection 2018. Review.

3.

Potential advantages of CD1-restricted T cell immunotherapy in cancer.

Consonni M, Dellabona P, Casorati G.

Mol Immunol. 2018 Nov;103:200-208. doi: 10.1016/j.molimm.2018.09.025. Epub 2018 Oct 8. Review.

PMID:
30308433
4.

Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression.

Cortesi F, Delfanti G, Grilli A, Calcinotto A, Gorini F, Pucci F, Lucianò R, Grioni M, Recchia A, Benigni F, Briganti A, Salonia A, De Palma M, Bicciato S, Doglioni C, Bellone M, Casorati G, Dellabona P.

Cell Rep. 2018 Mar 13;22(11):3006-3020. doi: 10.1016/j.celrep.2018.02.058.

5.

Guidelines for the use of flow cytometry and cell sorting in immunological studies.

Cossarizza A, Chang HD, Radbruch A, Akdis M, Andrä I, Annunziato F, Bacher P, Barnaba V, Battistini L, Bauer WM, Baumgart S, Becher B, Beisker W, Berek C, Blanco A, Borsellino G, Boulais PE, Brinkman RR, Büscher M, Busch DH, Bushnell TP, Cao X, Cavani A, Chattopadhyay PK, Cheng Q, Chow S, Clerici M, Cooke A, Cosma A, Cosmi L, Cumano A, Dang VD, Davies D, De Biasi S, Del Zotto G, Della Bella S, Dellabona P, Deniz G, Dessing M, Diefenbach A, Di Santo J, Dieli F, Dolf A, Donnenberg VS, Dörner T, Ehrhardt GRA, Endl E, Engel P, Engelhardt B, Esser C, Everts B, Dreher A, Falk CS, Fehniger TA, Filby A, Fillatreau S, Follo M, Förster I, Foster J, Foulds GA, Frenette PS, Galbraith D, Garbi N, García-Godoy MD, Geginat J, Ghoreschi K, Gibellini L, Goettlinger C, Goodyear CS, Gori A, Grogan J, Gross M, Grützkau A, Grummitt D, Hahn J, Hammer Q, Hauser AE, Haviland DL, Hedley D, Herrera G, Herrmann M, Hiepe F, Holland T, Hombrink P, Houston JP, Hoyer BF, Huang B, Hunter CA, Iannone A, Jäck HM, Jávega B, Jonjic S, Juelke K, Jung S, Kaiser T, Kalina T, Keller B, Khan S, Kienhöfer D, Kroneis T, Kunkel D, Kurts C, Kvistborg P, Lannigan J, Lantz O, Larbi A, LeibundGut-Landmann S, Leipold MD, Levings MK, Litwin V, Liu Y, Lohoff M, Lombardi G, Lopez L, Lovett-Racke A, Lubberts E, Ludewig B, Lugli E, Maecker HT, Martrus G, Matarese G, Maueröder C, McGrath M, McInnes I, Mei HE, Melchers F, Melzer S, Mielenz D, Mills K, Mirrer D, Mjösberg J, Moore J, Moran B, Moretta A, Moretta L, Mosmann TR, Müller S, Müller W, Münz C, Multhoff G, Munoz LE, Murphy KM, Nakayama T, Nasi M, Neudörfl C, Nolan J, Nourshargh S, O'Connor JE, Ouyang W, Oxenius A, Palankar R, Panse I, Peterson P, Peth C, Petriz J, Philips D, Pickl W, Piconese S, Pinti M, Pockley AG, Podolska MJ, Pucillo C, Quataert SA, Radstake TRDJ, Rajwa B, Rebhahn JA, Recktenwald D, Remmerswaal EBM, Rezvani K, Rico LG, Robinson JP, Romagnani C, Rubartelli A, Ruckert B, Ruland J, Sakaguchi S, Sala-de-Oyanguren F, Samstag Y, Sanderson S, Sawitzki B, Scheffold A, Schiemann M, Schildberg F, Schimisky E, Schmid SA, Schmitt S, Schober K, Schüler T, Schulz AR, Schumacher T, Scotta C, Shankey TV, Shemer A, Simon AK, Spidlen J, Stall AM, Stark R, Stehle C, Stein M, Steinmetz T, Stockinger H, Takahama Y, Tarnok A, Tian Z, Toldi G, Tornack J, Traggiai E, Trotter J, Ulrich H, van der Braber M, van Lier RAW, Veldhoen M, Vento-Asturias S, Vieira P, Voehringer D, Volk HD, von Volkmann K, Waisman A, Walker R, Ward MD, Warnatz K, Warth S, Watson JV, Watzl C, Wegener L, Wiedemann A, Wienands J, Willimsky G, Wing J, Wurst P, Yu L, Yue A, Zhang Q, Zhao Y, Ziegler S, Zimmermann J.

Eur J Immunol. 2017 Oct;47(10):1584-1797. doi: 10.1002/eji.201646632. No abstract available.

6.

Harnessing the CD1 restricted T cell response for leukemia adoptive immunotherapy.

Consonni M, de Lalla C, Bigi A, Dellabona P, Casorati G.

Cytokine Growth Factor Rev. 2017 Aug;36:117-123. doi: 10.1016/j.cytogfr.2017.06.007. Epub 2017 Jul 8. Review.

PMID:
28712863
7.

Of self-lipids, CD1-restricted T cells, and contact sensitization.

Casorati G, Dellabona P.

Eur J Immunol. 2017 Jul;47(7):1119-1122. doi: 10.1002/eji.201747112.

8.

Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis.

Gorini F, Azzimonti L, Delfanti G, Scarfò L, Scielzo C, Bertilaccio MT, Ranghetti P, Gulino A, Doglioni C, Di Napoli A, Capri M, Franceschi C, Caligaris-Cappio F, Ghia P, Bellone M, Dellabona P, Casorati G, de Lalla C.

Blood. 2017 Jun 29;129(26):3440-3451. doi: 10.1182/blood-2016-11-751065. Epub 2017 May 2.

9.

miR-17∼92 family clusters control iNKT cell ontogenesis via modulation of TGF-β signaling.

Fedeli M, Riba M, Garcia Manteiga JM, Tian L, Viganò V, Rossetti G, Pagani M, Xiao C, Liston A, Stupka E, Cittaro D, Abrignani S, Provero P, Dellabona P, Casorati G.

Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):E8286-E8295. doi: 10.1073/pnas.1612024114. Epub 2016 Dec 5.

10.

T cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genes.

Mennonna D, Maccalli C, Romano MC, Garavaglia C, Capocefalo F, Bordoni R, Severgnini M, De Bellis G, Sidney J, Sette A, Gori A, Longhi R, Braga M, Ghirardelli L, Baldari L, Orsenigo E, Albarello L, Zino E, Fleischhauer K, Mazzola G, Ferrero N, Amoroso A, Casorati G, Parmiani G, Dellabona P.

Gut. 2017 Mar;66(3):454-463. doi: 10.1136/gutjnl-2015-309453. Epub 2015 Dec 17.

11.

The circulating microRNome demonstrates distinct lymphocyte subset-dependent signatures.

de Candia P, Torri A, Fedeli M, Viganò V, Carpi D, Gorletta T, Casorati G, Pagani M, Dellabona P, Abrignani S.

Eur J Immunol. 2016 Mar;46(3):725-31. doi: 10.1002/eji.201545787. Epub 2015 Dec 29.

12.

Alliance Against Cancer, the network of Italian cancer centers bridging research and care.

De Paoli P, Ciliberto G, Ferrarini M, Pelicci P, Dellabona P, De Lorenzo F, Mantovani A, Musto P, Opocher G, Picci P, Ricciardi W, De Maria R.

J Transl Med. 2015 Nov 14;13:360. doi: 10.1186/s12967-015-0711-x.

13.

Group 1 CD1-restricted T cells and the pathophysiological implications of self-lipid antigen recognition.

Dellabona P, Consonni M, de Lalla C, Casorati G.

Tissue Antigens. 2015 Dec;86(6):393-405. doi: 10.1111/tan.12689. Epub 2015 Oct 30. Review.

PMID:
26514448
14.

A Subset of CD8αβ+ Invariant NKT Cells in a Humanized Mouse Model.

Wen X, Kim S, Xiong R, Li M, Lawrenczyk A, Huang X, Chen SY, Rao P, Besra GS, Dellabona P, Casorati G, Porcelli SA, Akbari O, Exley MA, Yuan W.

J Immunol. 2015 Aug 15;195(4):1459-69. doi: 10.4049/jimmunol.1500574. Epub 2015 Jul 8.

15.

Targeting leukemia by CD1c-restricted T cells specific for a novel lipid antigen.

Lepore M, de Lalla C, Mori L, Dellabona P, De Libero G, Casorati G.

Oncoimmunology. 2014 Dec 3;4(3):e970463. eCollection 2015 Mar.

16.

Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer.

Trajanoski Z, Maccalli C, Mennonna D, Casorati G, Parmiani G, Dellabona P.

Cancer Immunol Immunother. 2015 Jan;64(1):99-104. doi: 10.1007/s00262-014-1599-7. Epub 2014 Aug 28. Review.

PMID:
25164877
17.

A novel self-lipid antigen targets human T cells against CD1c(+) leukemias.

Lepore M, de Lalla C, Gundimeda SR, Gsellinger H, Consonni M, Garavaglia C, Sansano S, Piccolo F, Scelfo A, Häussinger D, Montagna D, Locatelli F, Bonini C, Bondanza A, Forcina A, Li Z, Ni G, Ciceri F, Jenö P, Xia C, Mori L, Dellabona P, Casorati G, De Libero G.

J Exp Med. 2014 Jun 30;211(7):1363-77. doi: 10.1084/jem.20140410. Epub 2014 Jun 16.

18.

iNKT-cell help to B cells: a cooperative job between innate and adaptive immune responses.

Dellabona P, Abrignani S, Casorati G.

Eur J Immunol. 2014 Aug;44(8):2230-7. doi: 10.1002/eji.201344399. Epub 2014 May 30. Review.

19.

Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4.

Volonté A, Di Tomaso T, Spinelli M, Todaro M, Sanvito F, Albarello L, Bissolati M, Ghirardelli L, Orsenigo E, Ferrone S, Doglioni C, Stassi G, Dellabona P, Staudacher C, Parmiani G, Maccalli C.

J Immunol. 2014 Jan 1;192(1):523-32. doi: 10.4049/jimmunol.1301342. Epub 2013 Nov 25.

20.

Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation.

de Candia P, Torri A, Gorletta T, Fedeli M, Bulgheroni E, Cheroni C, Marabita F, Crosti M, Moro M, Pariani E, Romanò L, Esposito S, Mosca F, Rossetti G, Rossi RL, Geginat J, Casorati G, Dellabona P, Pagani M, Abrignani S.

PLoS One. 2013 Sep 26;8(9):e75348. doi: 10.1371/journal.pone.0075348. eCollection 2013.

21.

Functional education of invariant NKT cells by dendritic cell tuning of SHP-1.

Napolitano A, Pittoni P, Beaudoin L, Lehuen A, Voehringer D, MacDonald HR, Dellabona P, Casorati G.

J Immunol. 2013 Apr 1;190(7):3299-308. doi: 10.4049/jimmunol.1203466. Epub 2013 Feb 20.

23.

Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4(+) T cell help.

Tonti E, Fedeli M, Napolitano A, Iannacone M, von Andrian UH, Guidotti LG, Abrignani S, Casorati G, Dellabona P.

J Immunol. 2012 Apr 1;188(7):3217-22. doi: 10.4049/jimmunol.1103501. Epub 2012 Feb 29.

24.

Loss of T cell microRNA provides systemic protection against autoimmune pathology in mice.

Tian L, De Hertogh G, Fedeli M, Staats KA, Schonefeldt S, Humblet-Baron S, Van Den Bosch L, Dellabona P, Dooley J, Liston A.

J Autoimmun. 2012 Feb;38(1):39-48. doi: 10.1016/j.jaut.2011.12.004. Epub 2012 Jan 4.

25.

Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation.

Locatelli F, Vinti L, Palumbo G, Rossi F, Bertaina A, Mastronuzzi A, Bernardo ME, Rutella S, Dellabona P, Giorgiani G, Moretta A, Moretta L.

Best Pract Res Clin Haematol. 2011 Sep;24(3):339-49. doi: 10.1016/j.beha.2011.04.004. Epub 2011 Jul 7. Review.

PMID:
21925087
26.

Fine tuning by human CD1e of lipid-specific immune responses.

Facciotti F, Cavallari M, Angénieux C, Garcia-Alles LF, Signorino-Gelo F, Angman L, Gilleron M, Prandi J, Puzo G, Panza L, Xia C, Wang PG, Dellabona P, Casorati G, Porcelli SA, de la Salle H, Mori L, De Libero G.

Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14228-33. doi: 10.1073/pnas.1108809108. Epub 2011 Aug 15.

27.

An unexpected requirement for CD4+ T cells in anti-glycolipid antibody responses.

Dellabona P, Casorati G.

Immunol Cell Biol. 2011 May;89(4):499-501. doi: 10.1038/icb.2011.21. Epub 2011 Apr 12. No abstract available.

PMID:
21483447
28.

Invariant NKT cell reconstitution in pediatric leukemia patients given HLA-haploidentical stem cell transplantation defines distinct CD4+ and CD4- subset dynamics and correlates with remission state.

de Lalla C, Rinaldi A, Montagna D, Azzimonti L, Bernardo ME, Sangalli LM, Paganoni AM, Maccario R, Di Cesare-Merlone A, Zecca M, Locatelli F, Dellabona P, Casorati G.

J Immunol. 2011 Apr 1;186(7):4490-9. doi: 10.4049/jimmunol.1003748. Epub 2011 Feb 25.

29.

High-frequency and adaptive-like dynamics of human CD1 self-reactive T cells.

de Lalla C, Lepore M, Piccolo FM, Rinaldi A, Scelfo A, Garavaglia C, Mori L, De Libero G, Dellabona P, Casorati G.

Eur J Immunol. 2011 Mar;41(3):602-10. doi: 10.1002/eji.201041211. Epub 2011 Jan 18.

30.

On the use of donor-derived iNKT cells for adoptive immunotherapy to prevent leukemia recurrence in pediatric recipients of HLA haploidentical HSCT for hematological malignancies.

Dellabona P, Casorati G, de Lalla C, Montagna D, Locatelli F.

Clin Immunol. 2011 Aug;140(2):152-9. doi: 10.1016/j.clim.2010.11.015. Epub 2010 Dec 24. Review.

PMID:
21185785
31.

An efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinoma.

Canderan G, Gruarin P, Montagna D, Fontana R, Campi G, Melloni G, Traversari C, Dellabona P, Casorati G.

PLoS One. 2010 Aug 9;5(8):e12014. doi: 10.1371/journal.pone.0012014. Erratum in: PLoS One. 2011;6(1).doi: 10.1371/annotation/df559170-4836-4bc7-a16d-44c7c6339cda. Campi, Gabriele [added].

32.

T helper 17 T cells do good for cancer immunotherapy.

Canderan G, Dellabona P.

Immunotherapy. 2010 Jan;2(1):21-4. doi: 10.2217/imt.09.83.

PMID:
20635888
33.

The CD4+ T-cell epitope-binding register is a critical parameter when generating functional HLA-DR tetramers with promiscuous peptides.

Cecconi V, Moro M, Del Mare S, Sidney J, Bachi A, Longhi R, Sette A, Protti MP, Dellabona P, Casorati G.

Eur J Immunol. 2010 Jun;40(6):1603-16. doi: 10.1002/eji.200940123.

34.

iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells.

Bellone M, Ceccon M, Grioni M, Jachetti E, Calcinotto A, Napolitano A, Freschi M, Casorati G, Dellabona P.

PLoS One. 2010 Jan 13;5(1):e8646. doi: 10.1371/journal.pone.0008646.

35.

Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells.

Li X, Shiratsuchi T, Chen G, Dellabona P, Casorati G, Franck RW, Tsuji M.

J Immunol. 2009 Oct 1;183(7):4415-21. doi: 10.4049/jimmunol.0901021. Epub 2009 Sep 4. Erratum in: J Immunol. 2010 Jan 15;184(2):1121.

36.

Dicer-dependent microRNA pathway controls invariant NKT cell development.

Fedeli M, Napolitano A, Wong MP, Marcais A, de Lalla C, Colucci F, Merkenschlager M, Dellabona P, Casorati G.

J Immunol. 2009 Aug 15;183(4):2506-12. doi: 10.4049/jimmunol.0901361. Epub 2009 Jul 22.

37.

The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function.

Locci M, Draghici E, Marangoni F, Bosticardo M, Catucci M, Aiuti A, Cancrini C, Marodi L, Espanol T, Bredius RG, Thrasher AJ, Schulz A, Litzman J, Roncarolo MG, Casorati G, Dellabona P, Villa A.

J Exp Med. 2009 Apr 13;206(4):735-42. doi: 10.1084/jem.20081773. Epub 2009 Mar 23.

38.

B cell helper assays.

Abrignani S, Tonti E, Casorati G, Dellabona P.

Methods Mol Biol. 2009;514:15-26. doi: 10.1007/978-1-60327-527-9_2.

PMID:
19048210
39.

Carcinoembryonic antigen-specific but not antiviral CD4+ T cell immunity is impaired in pancreatic carcinoma patients.

Tassi E, Gavazzi F, Albarello L, Senyukov V, Longhi R, Dellabona P, Doglioni C, Braga M, Di Carlo V, Protti MP.

J Immunol. 2008 Nov 1;181(9):6595-603.

40.

NKT-cell help to B lymphocytes can occur independently of cognate interaction.

Tonti E, Galli G, Malzone C, Abrignani S, Casorati G, Dellabona P.

Blood. 2009 Jan 8;113(2):370-6. doi: 10.1182/blood-2008-06-166249. Epub 2008 Oct 2.

41.

Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions.

Cecconi V, Moro M, Del Mare S, Dellabona P, Casorati G.

Cytometry A. 2008 Nov;73(11):1010-8. doi: 10.1002/cyto.a.20603.

42.

Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop.

Exley MA, Hou R, Shaulov A, Tonti E, Dellabona P, Casorati G, Akbari O, Akman HO, Greenfield EA, Gumperz JE, Boyson JE, Balk SP, Wilson SB.

Eur J Immunol. 2008 Jun;38(6):1756-66. doi: 10.1002/eji.200737389.

43.

Innate-like effector differentiation of human invariant NKT cells driven by IL-7.

de Lalla C, Festuccia N, Albrecht I, Chang HD, Andolfi G, Benninghoff U, Bombelli F, Borsellino G, Aiuti A, Radbruch A, Dellabona P, Casorati G.

J Immunol. 2008 Apr 1;180(7):4415-24.

44.

Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules.

Denkberg G, Stronge VS, Zahavi E, Pittoni P, Oren R, Shepherd D, Salio M, McCarthy C, Illarionov PA, van der Merwe A, Besra GS, Dellabona P, Casorati G, Cerundolo V, Reiter Y.

Eur J Immunol. 2008 Mar;38(3):829-40. doi: 10.1002/eji.200737518.

45.

Serological immunoreactivity against colon cancer proteome varies upon disease progression.

De Monte L, Sanvito F, Olivieri S, Viganò F, Doglioni C, Frasson M, Braga M, Bachi A, Dellabona P, Protti MP, Alessio M.

J Proteome Res. 2008 Feb;7(2):504-14. doi: 10.1021/pr070360m. Epub 2008 Jan 8.

PMID:
18179166
46.

CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells.

Thedrez A, de Lalla C, Allain S, Zaccagnino L, Sidobre S, Garavaglia C, Borsellino G, Dellabona P, Bonneville M, Scotet E, Casorati G.

Blood. 2007 Jul 1;110(1):251-8. Epub 2007 Mar 15.

47.

Invariant NKT cells sustain specific B cell responses and memory.

Galli G, Pittoni P, Tonti E, Malzone C, Uematsu Y, Tortoli M, Maione D, Volpini G, Finco O, Nuti S, Tavarini S, Dellabona P, Rappuoli R, Casorati G, Abrignani S.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3984-9. Epub 2007 Feb 27.

48.

T cell recognition of lipids: quo vadis?

De Libero G, Macdonald HR, Dellabona P.

Nat Immunol. 2007 Mar;8(3):223-7. No abstract available. Erratum in: Nat Immunol. 2007 Apr;8(4):438.

PMID:
17304228
49.

[Laparoscopic-assisted versus open surgery for colorectal cancer: postoperative morbidity in a single center randomized trial].

Frasson M, Braga M, Vignali A, Zuliani W, Gruarin P, Dellabona P, Di Carlo V.

Minerva Chir. 2006 Aug;61(4):283-92. Italian.

PMID:
17122760
50.

Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia.

Montagna D, Maccario R, Locatelli F, Montini E, Pagani S, Bonetti F, Daudt L, Turin I, Lisini D, Garavaglia C, Dellabona P, Casorati G.

Blood. 2006 Dec 1;108(12):3843-50. Epub 2006 Jul 25.

Supplemental Content

Loading ...
Support Center